Related Experiment Videos
Phospholipase A2 activity in human osteoarthritic cartilage
The Journal of Rheumatology. Supplement
|August 1, 1989
Summary
Osteoarthritis (OA) cartilage shows increased phospholipase A2 (PLA2) activity, linked to proteoglycanase but not collagenase. Tiaprofenic acid may offer chondroprotection by modulating these enzymes.
Area of Science:
- Biochemistry
- Orthopedics
- Pharmacology
Background:
- Articular cartilage degradation is a hallmark of osteoarthritis (OA).
- Enzymatic activity, particularly phospholipase A2 (PLA2), plays a role in cartilage metabolism.
- Understanding these enzymatic pathways is crucial for developing effective OA treatments.
Purpose of the Study:
- To investigate phospholipase A2 (PLA2) activity in normal and osteoarthritic (OA) human articular cartilage.
- To determine the relationship between PLA2 activity, proteoglycanase, and collagenase activity in OA cartilage.
- To evaluate the in vitro effects of tiaprofenic acid on PLA2 and proteoglycanase activity.
Main Methods:
- Measurement of phospholipase A2 (PLA2) activity in human femoral head cartilage specimens.
- Quantification of proteoglycanase and collagenase activity using radiolabeled substrates.
- In vitro assessment of tiaprofenic acid's impact on enzyme activities.
Main Results:
- Significantly increased PLA2 activity was observed in grossly normal and fibrillated OA cartilage, but not in osteophytic cartilage.
- PLA2 activity positively correlated with proteoglycanase activity but showed no correlation with collagenase activity.
- Tiaprofenic acid treatment in vitro resulted in a simultaneous increase in PLA2 activity and a decrease in proteoglycanase activity.
Conclusions:
- PLA2 is implicated as a key enzyme in regulating chondrocyte metabolism, potentially influenced by cytokines and mechanical factors.
- Tiaprofenic acid demonstrates potential as a chondroprotective agent within the nonsteroidal anti-inflammatory drug (NSAID) class.